Sintilimab combined with Tiggio for maintenance therapy after first-line treatment of advanced biliary tumors: a single-arm, phase II clinical trial
Latest Information Update: 02 Dec 2020
Price :
$35 *
At a glance
- Drugs Sintilimab (Primary)
- Indications Biliary cancer; Carcinoma; Cholangiocarcinoma; Gallbladder cancer
- Focus Therapeutic Use
- 02 Dec 2020 New trial record